Fecal microbial biomarkers combined with multi-target stool DNA test improve diagnostic accuracy for colorectal cancer

Table 1 Basic demographic and clinical characteristics of cases and controls

Variable	Colorectal cancer patients	Health controls	P value
Gender			0.30
Male	34 (62.96)	27 (52.94)
Female	20 (37.04)	24 (47.06)
Age			0.00
mean ± SD	64.89 ± 9.72	53.94 ± 10.33
< 60 yr	18 (33.33)	35 (68.63)
≥ 60 yr	36 (66.67)	16 (31.37)
Education level			0.00
Junior high school and below	43 (79.63)	10 (19.61)
Senior high school and above	11 (20.37)	41 (80.39)
BMI (kg/m2)			0.00
≤ 18.5	4 (7.41)	0 (0.00)
18.5-23.9	37 (68.52)	24 (47.06)
≥ 24	13 (24.07)	27 (52.94)
Tumor location
Colon	36 (66.67)	-	-
Rectum	18 (33.33)	-	-
Pathogenic type		-	-
Protrude type	10 (18.52)	-	-
Infiltrating type	11 (20.37)	-	-
Ulcerative type	33 (61.11)	-	-
Differentiation		-	-
High	4 (7.41)	-	-
Medium/low	50 (92.59)	-	-
Histological type		-	-
Adenocarcinoma	54 (100.00)	-	-
Other types	0 (0.00)	-	-
Dukes stage		-	-
A	43 (79.63)	-	-
B	7 (12.96)	-	-
C	4 (7.41)	-	-
D	0 (0.0)	-	-

BMI: Body mass index.